Estrogens up-regulate expression of the estrogen receptor alpha (ER) gene in most mammalian tissues studied. Using the ovariectomized ewe as a model, we determined that estradiol (E 2 ) acted post-transcriptionally to increase endometrial ER mRNA concentrations by enhancing the stability of the message. The purpose of this study was to determine whether a similar E 2 effect occurs in Ishikawa cells, a well-differentiated human endometrial adenocarcinoma cell line. The presence and function of ER protein in Ishikawa cells was demonstrated by transactivation of a transfected plasmid (ERE 2 tkCAT) in response to 10 −9 M E 2 , resulting in a 550% increase in reporter gene RNA. Ishikawa cells also responded to E 2 by up-regulating their ER mRNA concentration an average of 100% between 7 and 24 h of treatment. The effect of E 2 on ER mRNA stability was measured after blocking transcription with actinomycin D to find that the half-life increased from 6 to 10 h in control and E 2 -treated cells respectively. These results are consistent with cell-free studies which showed significant enhancement of the half-life of radiolabeled ER 3′ untranslated region (3′UTR) RNA in extracts from E 2 -treated cells versus those from control cells. Thus, Ishikawa cells provide a relevant model system for the study of E 2 -regulated endometrial gene expression.
Introduction
During times of natural estrogen dominance, both estrogen receptor alpha (ER) mRNA and protein levels increase in endometrium in species ranging from rodents to humans (Lessey et al. 1988 , Brenner et al. 1991 , Bergman et al. 1992 , Geisert et al. 1993 , Ott et al. 1993 , Zheng et al. 1996 . Similarly, physiological doses of estradiol (E 2 ) up-regulate endometrial ER gene expression in ovariectomized animals (Bergman et al. 1992 , Okulicz et al. 1990 , Ing et al. 1996 . Our previous work showed that E 2 up-regulated ER mRNA levels 400% in 24 h by a post-transcriptional mechanism: by stabilizing the ER message without affecting the rate of ER gene transcription (Ing et al. 1996 , Ing & Ott 1999 . ER mRNA (6500 bases long) is unstable because of its 4000 base long 3 untranslated region (3 UTR) which contains many AUUUA motifs, as do the typically unstable proto-oncogene mRNAs (Keaveney et al. 1993 , Kenealy et al. 2000 . Therefore, E 2 may stabilize endometrial ER mRNA similar to the way it stabilizes egg protein mRNAs in the livers of egg-laying animals: by inducing proteins that bind to specific sequences in the 3'UTR (Flouriot et al. 1996 , Dodson & Shapiro 1997 .
In order to define the molecular mechanisms by which E 2 up-regulates ER mRNA in endometrium, a physiologically relevant cell culture system is required to be able to mutate ER mRNA sequences and analyze resultant effects on stability in a living system. Literature searches found no reports of estrogen up-regulation of ER gene expression in any cell line derived from endometrium. In fact, expression of ER and progesterone receptor (PR) genes is commonly lost when uterine cells are placed in culture (Helftenbein et al. 1991) . The most common model for studying autoregulation of ER gene expression is the MCF7 breast cancer cell line. However, it shows down-regulation of ER mRNA and protein with E 2 treatment and the effect appears to be due to reduced stability of ER mRNA (Saceda et al. 1988 , Berkenstam et al. 1989 , Ree et al. 1989 , Borras et al. 1994 , Saceda et al. 1998 . This contrasts with the natural up-regulation of ER gene expression by estrogens in uterus and breast during estrous and menstrual cycles (Anderson et al. 1998) .
The Ishikawa cell line, well-differentiated cells derived from a human endometrial adenocarcinoma (Nishida et al. 1985) , appear to be an exception. Ishikawa cells express steroid hormone receptor genes including ER and PR. The ER gene products, both mRNA and protein, predominate over those of estrogen receptor beta in Ishikawa cells as in the uterus , Paech et al. 1997 , Nuttall et al. 2001 , Wormke et al. 2000 . In addition, Ishikawa cells maintain natural autoregulation of PR gene expression: up-regulation by E 2 and down-regulation by progesterone (Holinka et al. 1986 , Anzai et al. 1989 , Jamil et al. 1991 , Hata & Kuramoto 1992 , Lessey et al. 1996 , Pinelli et al. 1998 ). E 2 affects Ishikawa cells similar to endometrium in altering expression of alkaline phosphatase, transforming growth factors-alpha and -beta, integrins, basic fibroblast growth factor, and androgen receptor genes (Anzai et al. 1989 , Lessey et al. 1996 , Fujimoto et al. 1997 , Lovely et al. 2000 .
The purpose of this study was to determine if Ishikawa cells would provide a relevant model for future studies of the E 2 -induced up-regulation of ER mRNA that occurs in endometrium. Criteria were that the model should express the ER gene and respond to physiological levels of E 2 by activating transcription of a reporter gene. In addition, the cultured cells should respond to E 2 by up-regulating ER mRNA within 24 h by stabilizing the message, as does endometrium. The cell cultures that fulfill these criteria should provide a useful model system for identifying the ER mRNA sequences and binding proteins important to E 2 up-regulation of ER gene expression.
Materials and Methods

Cell culture
Ishikawa cells were grown and maintained in DME-F12 medium containing 5% (v/v) fetal bovine serum (FBS, Hyclone, Logan, UT, USA), 100 U/ml penicillin G and 100 µg/ml streptomycin (GIBCO/BRL, Frederick, MD, USA). Passage numbers were between 20 and 40, with cells split consistently 1:5 every other day. Three days prior to experiments, medium was changed to 'steroid-depleted medium': DME-F12 without phenol red and with 5% dextran-charcoalstripped FBS (Hyclone) and 100 U/ml sodium penicillin G and 100 µg/ml streptomycin sulfate. At treatment initiation, cells were exposed to the indicated concentration of E 2 or the drug vehicle (0·1% ethanol). Chemicals were of molecular biology or cell culture grade as appropriate and, unless otherwise indicated, were purchased from Sigma Chemical Co.
ER activation of transfected estrogen-responsive promoter constructs
On six-well cell culture plates, 6 10 4 Ishikawa cells plated the day before reached 60% confluence in steroid-depleted medium. In triplicate wells, the cells were transfected with no DNA ('mock transfection') or 1 µg each of plasmids pERE 2 tkCAT (Klein-Hitpass et al. 1989 ) and 1 µg pEGFP-C1 (Clontech) following the Superfect protocol (Qiagen). The first plasmid contained the chloramphenicol acetyltransferase (CAT) reporter gene under transcriptional control of estrogenresponse elements (EREs) to measure ER transactivation. The second plasmid contained the enhanced green fluorescent protein (EGFP) reporter gene under the transcriptional control of the cytomegalovirus promoter and was used as a control for transfection efficiency. At 18 h posttransfection, cells were treated with 10 9 M E 2 or drug vehicle. Then 24 h after E 2 treatment, green fluorescent cells were visualized on an Eclipse TE 300 Microscope (Nikon, Melville, NY, USA) immediately prior to RNA isolation for analysis of CAT mRNA.
Synthesis of mRNA probes
To probe Northern blots for CAT and ER mRNAs, antisense cRNA probes were made from the pTRI-CAT DNA template (Ambion, Austin, TX, USA) and poER8 (Ing et al. 1996) respectively. For the cell-free RNA stability assays, a sense cRNA probe containing the entire 4000 base long 3 UTR of the ovine ER mRNA was synthesized from EcoR V-restricted poER-RACE2 plasmid (cDNA (GenBank accession AY033393) cloned into pCR 2·1 vector with the TA cloning kit (Invitrogen). As an E 2 -insensitive control in the cell-free stability assay, a fragment of the 28S rRNA (encompassing the 989 base long HincII to BamHI fragment of the 28S rRNA cDNA; Gonsalez et al. 1985) was radiolabeled similarly. Briefly, cRNA probes were generated by in vitro transcription with T7 RNA polymerase with the Maxiscript kit (Ambion) using [ 32 P]UTP (3000 Ci/mmol, New England Nuclear, Boston, MA, USA). For Northern blots, unincorporated radionucleotides were removed from antisense probes with spin columns (Bio 101, La Jolla, CA, USA), while the sense RNAs for the cell-free stability assays were purified on 5% acrylamide/8 M urea denaturing gels to ensure that the latter were all full-length molecules (Ing et al. 1996) .
Preparation of RNA samples and Northern analyses
Total cellular RNA samples were purified from live cell cultures with Tripure Reagent (Boehringer Mannheim). Extracted RNA was resuspended in TE buffer consisting of 50 mM Tris-Cl (pH 7·8) and 1 mM EDTA and stored at 80 C pending analysis. Northern blot analyses of total cellular RNA samples (5-8 µg, consistent across the set of samples to be compared on one gel and blot) were performed as previously described (Ing et al. 1996) . Stringent blot hybridization (55 C) and washing (68 C) in 0·1X SSC (1X=150 mM NaCl+15 mM Na citrate) containing 0·1% SDS were followed by treatment with 1 µg/ml RNase A (Boehringer Mannheim) in 2X SSC for 10 min at room temperature. After washing twice at 55 C in 0·1X SSC containing 0·1% SDS for 15 min, blots were exposed to Fuji RX autoradiographic film for times ranging from 12 h to 7 days in order to record hybridization signals in the linear range of the film.
The signal intensities were measured by densitometry using Adobe Photoshop (Mountain View, CA, USA) scanning and Intelligent Quantifier (BioImage, Ann Arbor, MI, USA) quantitation software. ER and CAT message sizes were confirmed as 6500 and 1350 bases by comparing migration distances to those of 28S and 18S rRNAs (4800 and 1800 bases respectively) on gels stained with ethidium bromide (EtBr).
Inhibition of transcription by actinomycin D or 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)
In order to find the most efficacious agent for blocking transcription in Ishikawa cells, inhibition of transcription by actinomycin D and 5,6-dichloro-1---ribofuranosylbenzimidazole (DRB) were assessed. Triplicate cultures of cells in steroid-depleted medium were exposed to actinomycin D (5 µg/ml) or its vehicle (ethanol to a final concentration of 0·25%), while others were exposed to DRB (75 µg/ml) or its vehicle (dimethylsulfoxide to a final concentration of 0·1%). After 30 min of transcription inhibitor treatment, 5 mCi of [5,6-3 H]uridine (40 Ci/mmol; New England Nuclear) was added to the medium for pulse-labeling of nascent RNA. Three hours later the medium was changed to 'chase' medium containing 2·5 mM unlabeled uridine and cytidine in addition to the transcription inhibitor. Cells were harvested 6 h after the addition of the [ 3 H]uridine, and RNA was immediately extracted using the Tripure Reagent. Total cellular RNA (10 µg) from each sample was used to purify poly(A) + RNA in duplicate preparations (Kingston 1997 , Ing & Ott 2000 ).
Incorporation of [
3 H]uridine into poly(A) + RNA was determined by scintillation counts of 10 µl aliquots of the poly(A) + preparations.
ER mRNA stability assays in Ishikawa cells
Triplicate cultures of cells were cultured in steroid-depleted medium with 10 9 M E 2 or drug vehicle for 24 h. At time 0 h, medium was exchanged for that containing 5 µg/ml actinomycin D plus E 2 or 0·1% ethanol. RNA samples were prepared from each of three triplicate cultures of E 2 -treated and untreated cells at time 0, 3, 6, 9 and 12 h. Northern analysis of ER mRNA was performed as described above.
Cell-free RNA stability analysis
High speed cytosolic extracts were prepared at 4 C (Ratnasabapathy et al. 1990 , Margot & Williams 1996 from Ishikawa cells treated for 24 h with 10 9 M E 2 or its vehicle, 0·1% ethanol. Briefly, 8 10 6 cells were homogenized in 400 µl of buffer containing 10 mM HEPES (pH 7·9), 1·5 mM MgCl 2 , 10 mM KCl, 0·5 mM dithiothreitol (DTT), and three protease inhibitors: 5 µg/ml aprotinin and 5 µg/ml leupeptin, 0·5 mM phenylmethylsulfonylfluoride. Large particles were removed by centrifugation at 800 g for 10 min. Then 0·11 volumes of buffer containing 30 mM HEPES (pH 7·9), 30 mM MgCl 2 , 1·4 M KCl and protease inhibitors were added and the extracts were centrifuged at 100 000 g for 60 min to remove nuclei and cell debris. The cytosolic extracts were dialyzed against 80 volumes of buffer containing 20 mM HEPES (pH 7·9), 20% glycerol, 0·2 mM ethylenediaminetetraacetate, 100 mM KCl, and protease inhibitors. Protein concentrations of extracts were determined using the Bio-Rad Protein Assay (BioRad). Aliquots of extracts were stored at 80 C until they were analyzed for the in vitro stability of the 3 UTR of the ER mRNA (Prokcipak et al. 1994 , Margot & Williams 1996 .
Cell-free RNA stability assays consisted of incubating cytosolic extracts (2·5 µg protein) from E 2 -treated or untreated Ishikawa cells with a radiolabeled ER 3 UTR or 28S RNA (1000 c.p.m.) in 10 mM Tris (pH 7·5), 60 mM KCl, 2 mM Mg acetate, 2 mM DTT, 10% glycerol, 2·5 µg/µl yeast tRNA, and 0·4 mM spermine for 30 min at 37 C. After reactions were treated with proteinase K, proteins were denatured in urea buffer and RNA was extracted with phenol-chloroform and precipitated with ethanol (Klein-Hitpass et al. 1990 ). Intact and degraded RNAs were separated on 1·5 mm thick denaturing 5% polyacrylamide gels (Bernstein et al. 1992) . Gels were dried and directly quantitated for the remaining intact ER RNA (migrating at the position of the full length RNA probe) on an InstantImager (Packard, Meriden, CT, USA).
Statistical analyses
Quantitative data were analyzed by Student's t-test (transfection assay and in vitro stability data), one-way ANOVA (E 2 dose and time-course data), and least squares ANOVA (transcription inhibitor trials) using SAS software (version 6·12 from the SAS Institute, Cary, NC, USA). Data are presented as means S.E. In Northern blot analyses, the hybridization signal of the ER mRNA band was divided by the intensity of the EtBr staining of the 18S rRNA in each lane (determined by densitometry) to normalize for the amount of RNA loaded. ER RNA half-lives (times to 50% of original concentrations) were estimated from semilogarithmic plots (Figs 4 and 6 ) of relative ER RNA levels on the y-axis (logarithmic) graphed against times on the x-axis (linear). The assumption that the RNA degrades with first-order kinetics was made (Hargrove et al. 1991) . Throughout the paper, P<0·05 was considered as the level of significance.
Results
ER protein is functional in Ishikawa cells
Because some reports in the literature have indicated a low or absent E 2 response in Ishikawa cells (Lee et al. 2000 , Mueller et al. 2000 , transfections were performed with an estrogenresponsive reporter plasmid, pERE 2 tkCAT, to assess the presence and function of ER protein in our cell cultures. Transfection efficiency was high and consistent across cultures, with about 25% of the cells demonstrating green fluorescence resulting from EGFP produced from the cotransfected pEGFP-C1 plasmid. RNA samples were analyzed for CAT RNA on Northern gels and subsequent blots. Representative analyses from mock transfections (no plasmid) and transfected cells treated with drug vehicle or E 2 are shown in lanes 1-3, respectively, of Since the signals at 1800 bases comigrated with 18S rRNA and were present even in mock-transfected cells, it was designated '18S rRNA' and presumed to be non-specific. Densitometric analyses of the CAT RNA bands in Northern blots from two experiments showed that E 2 treatment of Ishikawa cells transfected with pERE 2 tkCAT induced a 550% increase in CAT mRNA in transfected cells (P<0·05). This indicated that ER protein was both present and functional in our Ishikawa cells: it bound E 2 and activated transcription of the CAT reporter gene through its upstream pair of ERE sites. 8 M E 2 , or the E 2 vehicle (0·1% ethanol; '0 M E 2 '). Samples of total cellular RNA were analyzed on Northern blots for ER mRNA concentration by hybridization to a radiolabeled ER cRNA probe. Hybridization signals of ER mRNA at a migration position of 6500 bases (Ing et al. 1996) increased significantly (P<0·05) with 10 9 and 10 8 M E 2 treatments to levels about 50% higher than in vehicle-treated controls (Fig. 2) . The 10 10 M E 2 treatment showed no effect on ER mRNA levels. In three additional experiments, 10 8 M E 2 significantly increased the concentration of ER mRNA even more: to 100% greater levels than in vehicle-treated control cells (data not shown).
To determine the earliest time of the increase in ER mRNA, RNA was prepared from cell cultures after the addition of E 2 at 0, 1, 4, 7 and 10 h. The Northern blot analyses indicated that ER mRNA concentrations significantly increased at 7 and 10 h post-E 2 (P<0·05; Fig. 3 ). The levels of ER mRNA increased 150% over those in control (time=0 h) cells, a magnitude similar to that found in cells treated for 24 h (above).
E 2 stabilizes ER mRNA in Ishikawa cells: in vivo assays with inhibitors of transcription
Inhibition of mRNA transcription in cells with actinomycin D or DRB allows measurements of cellular RNAs over a subsequent time course to estimate their molecular stabilities. Two compounds with different modes of action are routinely used to block transcription: actinomycin D intercalates the DNA template, while DRB inhibits the transcription elongation factor TFIIH (Yankulov et al. 1995) . In order to find the most efficacious agent in our cell system, we evaluated the inhibition of [ 3 H]uridine incorporation into poly(A) + RNA in Ishikawa cells treated with actinomycin D (5 µg/ml) or DRB (75 µg/ml). Actinomycin D inhibited 93% while DRB blocked 50% of radiolabel incorporation compared with that in cultures treated with the respective drug's vehicle. Because of its higher efficacy, we used actinomycin D to inhibit transcription for our in vivo stability assays.
Ishikawa cells grown in steroid-depleted medium were treated with 10 9 M E 2 or vehicle for 24 h. At that time (time=0 h), 5 µg/ml actinomycin D was added to the medium of every cell culture. Total RNA was extracted from cells harvested at 3 h intervals and analyzed for ER mRNA concentrations on Northern blots. To contrast relative degradation rates, initial concentrations of ER mRNA were set at 100% for each treatment group. Figure 4 shows that the degradation of ER mRNA over time after transcription blockade occurred much faster in control cells ('No E 2 ') compared with that in the E 2 -treated ('E 2 ') cells. E 2 treatment significantly increased (P<0·05) the half-life (time to reduction to 50% of original levels) of the ER message from 6 h in control cells to 10 h in E 2 -treated cells.
E 2 treatment of Ishikawa cells stabilizes ER RNA: cell-free stability assays
In vitro transcription of the 3 UTR of the ER message provided a radiolabeled probe to assess Fig. 1 were treated with E 2 at the indicated doses. The drug vehicle, 0·1% ethanol, was applied to the controls ('0 M treatment'). After 24 h of treatment, RNA was harvested from triplicate cultures, each with approximately 10 6 cells, and analyzed individually for ER mRNA on Northern blots. Levels of ER mRNA are reported as least squares means and standard errors relative to the '0 M' dose treatment set at 100 for three replicate experiments. E 2 treatment at 10 −9 and 10 −8 M doses significantly increased ER mRNA levels (P<0·05) while 10 −10 M E 2 had no effect. Ishikawa cells were cultured as described in Fig. 1 , then treated with 10 −9 M E 2 as described in the Methods. Cells were harvested at time of E 2 treatment initiation ('0 h'), and at time points 1, 4, 7 and 10 h subsequent to it. Total cellular RNA was extracted from triplicate cultures of cells at the time of their harvest. Northern analyses indicated relative ER mRNA levels, reported as least squares means and standard errors, with the average hybridization signal of the RNA from the time '0 h' cultures set at 100. ER mRNA levels increased significantly at 7 and 10 h post-treatment (P<0·05).
whether the RNA was more stable in cytosolic extracts from E 2 -treated Ishikawa cells (24 h with 10 9 M E 2 ) compared with extracts from untreated cells. After a 30-min incubation of probe and extract at 37 C, degradation of the radiolabeled probe was analyzed on a denaturing acrylamide gel (Fig. 5) . The two lanes at left show the migration of duplicate samples of the intact 4000 base ER RNA probe ('Input') near the starting point of electrophoresis (upper thin arrow). The two middle lanes show severe degradation of the RNA probe to small fragments that migrate near the dye front of electrophoresis (lower thin arrow), a result of incubation with extract from untreated Ishikawa cells ('Ishikawa-E 2 '). In contrast, the duplicate RNA samples in the right lanes show much less degradation of the probe after incubation with the extract from E 2 -treated Ishikawa cells ('Ishikawa+E 2 '). Multiple experiments were analyzed for the percentage of intact RNA probe ) and E 2 -treated ('Ishikawa+E 2 ') cell extracts. The full-length ER RNA in the left lanes (4000 bases long, migration position indicated by thick arrow) was rapidly degraded to short fragments in extracts from untreated cells (near the bottom of the gel in the middle lanes, indicated by the lower thin arrow at left). E 2 treatment of cells, however, greatly reduced degradation of the ER RNA (right lanes) so more RNA migrated less far from the wells (upper thin arrow). These are representative results from three replicate experiments. (migrating at the position of the full length RNA probe) remaining after the incubations. E 2 treatment significantly increased (P<0·001) the percentage of intact RNA remaining from 9 4·7% in controls to 45 4·4%. The half-lives of ER RNA in E 2 -treated and untreated cell extracts were estimated from a semilogarithmic plot of the data (Fig. 6 ). E 2 significantly increased ER RNA half-life, from 7·5 to 30 min. This E 2 effect was specific for ER RNA because a 28S rRNA probe was equally stable in extracts from control and E 2 -treated Ishikawa cells, with 72% of the latter probe remaining intact after incubation in either extract (data not shown).
Estradiol in Ishikawa Cells
Discussion
This is the first report of E 2 up-regulating ER gene expression in an endometrial cell line. Only one ex vivo system of endometrial cell culture has previously recapitulated the in vivo up-regulation of ER gene expression by E 2 (Xiao & Goff 1999) . Those were primary cultures of epithelial cells from bovine endometrium, which demonstrated a 120% increase in ER protein levels after treatment with 10 9 M E 2 for 4 days. We set up similar experiments with primary cultures of sheep endometrial cells but had variable results (data not shown). As reported here, the Ishikawa cell line reliably reproduces the E 2 up-regulation of ER gene expression that occurs in endometrium.
A conflict in the literature exists between those reporting that Ishikawa cells have little or no expression of ER gene (Mueller et al. 2000) and those who observe robust E 2 responses and ER gene expression in their Ishikawa cells (Barsalou et al. 1998 , Wormke et al. 2000 . Therefore, an initial concern of ours was to demonstrate expression of the ultimate ER gene product, ER protein, in our cultures of Ishikawa cells. When we tested our Ishikawa cells for activation of the transfected ERE 2 tkCAT reporter gene, our data nearly matched the 700% increase in CAT gene expression in response to 2·5 10 9 M E 2 for 24 h (Wormke et al. 2000) . These studies also prove that Ishikawa cells are suitable for genetic manipulations, such as transfection of foreign DNA.
Our focus then turned to E 2 -regulated expression of the endogenous ER gene in Ishikawa cells. The same low dose of E 2 (10 9 M) that increased expression of pERE 2 tkCAT in transfected Ishikawa cells also up-regulated ER mRNA in untransfected cells. The magnitude of the E 2 -induced increase in ER mRNA levels in Ishikawa cells is consistent with that in the endometrium of ovariectomized ewes in response to a physiological dose of E 2 (Robertson et al. 1998 , Zou & Ing 1998 , Robertson et al. 2001 ). E 2 levels of 10 9 and 10 8 M have been used to up-regulate expression of the PR gene and other genes in Ishikawa cells (Holinka et al. 1986 , Jamil et al. 1991 , Lessey et al. 1996 , Pinelli et al. 1998 , Lovely et al. 2000 . Both are within the physiological range of circulating estrogen concentrations in female mammals during estrous and menstrual cycles (Guillemot et al. 1993) . Our time course study also illustrates the exquisite sensitivity of Ishikawa cells to E 2 , with the response reaching the peak induction within 7 h of treatment. We are aware of no other studies showing such a rapid effect of E 2 on Ishikawa cells: others have used 24 h as an initial time point (Lessey et al. 1996 , Wormke et al. 2000 and/or treated for 3 or more days (Holinka et al. 1986 , Jamil et al. 1991 , Barsalou et al. 1998 , Lovely et al. 2000 . The E 2 response measured here was faster than the up-regulation of ER mRNA in endometrium (present at 24 but not 12 h post-injection; Ing et al. 1996 , Ing & Tornesi 1997 . One possible reason for the faster response in cell culture is the lack of metabolism and clearance of the hormone during the treatment period.
Next, we determined whether Ishikawa cells shared a post-transcriptional mechanism of E 2 response with endometrium for up-regulation of ER mRNA. The stabilities of ER mRNAs were analyzed in both transcription inhibitor and cell-free assays. The results demonstrated that E 2 -treatment of Ishikawa cells significantly increased ER mRNA half-life by 70% and approximately 300% in the respective assays, similar to the 170% increase in ER RNA half-life in endometrium of E 2 -treated ovariectomized ewes (Ing & Ott 1999) . The ER mRNA half-life in Ishikawa cells was similar to that measured in MCF7 breast cancer cells (Saceda et al. 1998) . The half-lives in the cell-free assay were much shorter than those in living cells, probably due to lack of subcellular structures restricting RNase access to RNA and the lack of polyadenylation and capping on the synthetic RNA in the cell-free assay. We have seen similar differences between absolute values of half-lives of ER RNA in endometrial tissue and their cell-free extracts (Ing & Ott 1999, NH Ing & D Mitchell submitted) . As for the Ishikawa assays reported here, the increased ER RNA stability with E 2 treatment was consistent in both endometrial RNA stability assays.
Our conclusions are that the Ishikawa cell line maintains ER gene expression in culture and that the resultant ER protein powerfully activates transfected estrogen-responsive genes in a liganddependent manner. In addition, Ishikawa cells up-regulate the expression of their ER genes in response to E 2 by a post-transcriptional mechanism, as endometrium does in vivo. By transfecting reporter genes linked to ER mRNA sequences, the elements that confer its E 2 -modulated stability can now be defined in this physiologically relevant model system. Functional comparisons to the E 2 modulated stability of vitellogenin mRNA, sequences and the binding protein 'vigilin' that post-transcriptionally regulate gene expression in frog and chicken liver (Dodson & Shapiro 1997) may link this ancient mechanism of E 2 action to ER mRNA regulation in a mammalian cell.
